PRAC yields 644.44% · JNJ yields 2.14%● Live data
📍 PRAC pulled ahead of the other in Year 1
Combined, PRAC + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PRAC + JNJ for your $10,000?
Productivity Technologies Corp., through its subsidiaries, manufactures and sells automated industrial systems, industrial machinery and equipment, and custom electrical control panels. The company offers quick die change, press automation, flexible transfer, and stacking/destacking equipment used to automate automotive and other metal stamping operations. In addition, the company engages in the design, manufacture, and installation of custom electrical control panels primarily for use in production machinery and machine tools utilized in automotive, adhesive and sealant, food processing, and other industrial applications. It sells its products to automobile and automotive parts manufacturers, appliance manufacturers, and steel service centers, as well as manufacturers of lawn and garden equipment, office furniture, heating, ventilation and air conditioning equipment, and large construction equipment in the United States and internationally. Productivity Technologies Corp. was formerly known as Production Systems Acquisition Corporation and changed its name to Productivity Technologies Corp. in May 1996. The company was incorporated in 1993 and is based in Fenton, Michigan. It has sales and engineering offices in Michigan, Germany, and China.
Full PRAC Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.